Joan Brunet
机构: Hereditary Cancer Program, Catalan Institute of Oncology
每年引用次数
引用次数
引用: 12,183
H-指数: 58
I10-指数 : 184
出版物: 407
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
Menendez Javier , Vazquez-Martin Alejandro , Colomer Ramon , Brunet Joan
BMC Cancer 7
229
2007
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
LAURA S. SCHMIDT , MICHAEL L. NICKERSON , DEBORA ANGELONI , GLADYS M. GLENN
The Journal of Urology 172 ( 4) 1256 -1261
99
2004
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based study
Silvia de Sanjosé , Mélanie Léoné , Victoria Bérez , Angel Izquierdo
International Journal of Cancer 106 ( 4) 588 -593
97
2003
Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers
Jordi Ponce , Sergi Fernandez-Gonzalez , Iris Calvo , Maite Climent
International Journal of Gynecologic Cancer 30 ( 1) 83 -88
4
2020
ENSEÑAR BIOÉTICA A ESTUDIANTES DE MEDICINA MEDIANTE EL APRENDIZAJE BASADO EN PROBLEMAS (ABP)
Joaquim Bosch-Barrera , Joan Brunet , Ramon Farrés , Josep Ramis
Cuadernos de Bioética 26 ( 87) 303 -309
1
2015
Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
Ramon Colomer , Joana Relat , Diego Haro , Joan Brunet
Anticancer Research 28 3671 -3676
35
2008
Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient
Bruna Corominas-Faja , Begoña Martin-Castillo , Joaquim Bosch-Barrera , Javier A. Menendez
Anticancer Research 34 ( 8) 4323 -4327
16
2014
BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.
Paula Rofes , Jesús Del Valle , Sara Torres-Esquius , Lídia Feliubadaló
Genes 12 ( 2) 150
2021
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score
Gino M Dettorre , Saoirse Dolly , Angela Loizidou , John Chester
Clinical Cancer Research 27
2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
Gino M Dettorre , Saoirse Dolly , Angela Loizidou , John Chester
Journal for ImmunoTherapy of Cancer 9 ( 3)
1
2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
David J Pinato , Lorenza Scotti , Alessandra Gennari , Emeline Colomba-Blameble
European Journal of Cancer 150 190 -202
2021
Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic.
Judith Balmaña , Mónica Salinas , Joan Brunet , Angela Velasco
Genetics in Medicine 1 -8
2021
Response to letter entitled: Re: ERCC3 a new ovarian cancer susceptibility gene?
Agostina Stradella , Jesús Del Valle , Joan Brunet , Conxi Lázaro
European Journal of Cancer 150 281 -282
2021
Treatment focused genetic testing (TFGT) for ovarian cancer (OC) patients: The Catalan Institute of Oncology (ICO) network experience.
Maria Pilar Barretina-Ginesta , Hanan Ahmed-Ouahid , Beatriz Pardo , Marta Gil-Martin
Journal of Clinical Oncology 34
2016
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat , Daniel Barrowdale , Irene L Andrulis , Susan M Domchek
Cancer Epidemiology, Biomarkers & Prevention 21 ( 1) 134 -147
348
2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Fergus J Couch , Mia M Gaudet , Antonis C Antoniou , Susan J Ramus
Cancer Epidemiology, Biomarkers & Prevention 21 ( 4) 645 -657
43
2012
Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome.
Marta Domènech , Elia Grau , Ares Solanes , Angel Izquierdo
The Journal of Clinical Endocrinology and Metabolism 106 ( 2) 318 -325
3
2021
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.
Sara Verdura , Elisabet Cuyàs , Eric Cortada , Joan Brunet
Verdura, Sara Cuyàs, Elisabet Cortada, Eric Brunet i Vidal, Joan López Bonet, Eugeni Martin Castillo, Begoña Bosch Barrera, Joaquim Encinar, José Antonio Menéndez Menéndez, Javier Abel 2020 Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging-Us 12 ( 1) 8 -34
84
2020
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.
Elisabet Cuyàs , Juan Gumuzio , Sara Verdura , Joan Brunet
Aging 12 ( 6) 4794 -4814
36
2020
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.
Elisabet Cuyàs , Salvador Fernández-Arroyo , Maria Buxó , Sonia Pernas
Aging (Albany NY) 11 ( 9) 2874 -2888
10
2019